146 related articles for article (PubMed ID: 18421578)
1. Death receptor-4 (DR4) expression is regulated by transcription factor NF-kappaB in response to etoposide treatment.
Mendoza FJ; Ishdorj G; Hu X; Gibson SB
Apoptosis; 2008 Jun; 13(6):756-70. PubMed ID: 18421578
[TBL] [Abstract][Full Text] [Related]
2. Transcription factor NF-kappaB differentially regulates death receptor 5 expression involving histone deacetylase 1.
Shetty S; Graham BA; Brown JG; Hu X; Vegh-Yarema N; Harding G; Paul JT; Gibson SB
Mol Cell Biol; 2005 Jul; 25(13):5404-16. PubMed ID: 15964798
[TBL] [Abstract][Full Text] [Related]
3. Phytosphingosine in combination with TRAIL sensitizes cancer cells to TRAIL through synergistic up-regulation of DR4 and DR5.
Choi SY; Kim MJ; Chung HY; Lee SJ; Jang YJ
Oncol Rep; 2007 Jan; 17(1):175-84. PubMed ID: 17143496
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor-related apoptosis-inducing ligand-mediated activation of mitochondria-associated nuclear factor-kappaB in prostatic carcinoma cell lines.
Guseva NV; Taghiyev AF; Sturm MT; Rokhlin OW; Cohen MB
Mol Cancer Res; 2004 Oct; 2(10):574-84. PubMed ID: 15498932
[TBL] [Abstract][Full Text] [Related]
5. IFN-gamma/JAK/STAT pathway-induced inhibition of DR4 and DR5 expression on endothelial cells is cancelled by cycloheximide-sensitive mechanism: novel finding of cycloheximide-regulating death receptor expression.
Tanaka F; Kawakami A; Tamai M; Nakamura H; Iwanaga N; Izumi Y; Arima K; Aratake K; Huang M; Kamachi M; Ida H; Origuchi T; Eguchi K
Int J Mol Med; 2005 May; 15(5):833-9. PubMed ID: 15806306
[TBL] [Abstract][Full Text] [Related]
6. Resistance of melanoma cells to TRAIL does not result from upregulation of antiapoptotic proteins by NF-kappaB but is related to downregulation of initiator caspases and DR4.
Kurbanov BM; Fecker LF; Geilen CC; Sterry W; Eberle J
Oncogene; 2007 May; 26(23):3364-77. PubMed ID: 17160022
[TBL] [Abstract][Full Text] [Related]
7. TNF-alpha induces transient resistance to Fas-induced apoptosis in eosinophilic acute myeloid leukemia cells.
Qin Y; Auh S; Blokh L; Long C; Gagnon I; Hamann KJ
Cell Mol Immunol; 2007 Feb; 4(1):43-52. PubMed ID: 17349210
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase Cdelta activates RelA/p65 and nuclear factor-kappaB signaling in response to tumor necrosis factor-alpha.
Lu ZG; Liu H; Yamaguchi T; Miki Y; Yoshida K
Cancer Res; 2009 Jul; 69(14):5927-35. PubMed ID: 19549902
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of synthetic serine protease inhibitor (FUT-175)-mediated cell death.
Uwagawa T; Li Z; Chang Z; Xia Q; Peng B; Sclabas GM; Ishiyama S; Hung MC; Evans DB; Abbruzzese JL; Chiao PJ
Cancer; 2007 May; 109(10):2142-53. PubMed ID: 17410536
[TBL] [Abstract][Full Text] [Related]
10. NF-κB induces abnormal centrosome amplification by upregulation of CDK2 in laryngeal squamous cell cancer.
Liu JL; Ma HP; Lu XL; Sun SH; Guo X; Li FC
Int J Oncol; 2011 Oct; 39(4):915-24. PubMed ID: 21769424
[TBL] [Abstract][Full Text] [Related]
11. Evidence that the human death receptor 4 is regulated by activator protein 1.
Guan B; Yue P; Lotan R; Sun SY
Oncogene; 2002 May; 21(20):3121-9. PubMed ID: 12082627
[TBL] [Abstract][Full Text] [Related]
12. Constitutively activated nuclear factor-kappaB, but not induced NF-kappaB, leads to TRAIL resistance by up-regulation of X-linked inhibitor of apoptosis protein in human cancer cells.
Braeuer SJ; Büneker C; Mohr A; Zwacka RM
Mol Cancer Res; 2006 Oct; 4(10):715-28. PubMed ID: 17050666
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanism of tumor necrosis factor-alpha modulation of intestinal epithelial tight junction barrier.
Ye D; Ma I; Ma TY
Am J Physiol Gastrointest Liver Physiol; 2006 Mar; 290(3):G496-504. PubMed ID: 16474009
[TBL] [Abstract][Full Text] [Related]
14. p53 upregulates death receptor 4 expression through an intronic p53 binding site.
Liu X; Yue P; Khuri FR; Sun SY
Cancer Res; 2004 Aug; 64(15):5078-83. PubMed ID: 15289308
[TBL] [Abstract][Full Text] [Related]
15. Regulation of glutathione S-transferase P1-1 gene expression by NF-kappaB in tumor necrosis factor alpha-treated K562 leukemia cells.
Morceau F; Duvoix A; Delhalle S; Schnekenburger M; Dicato M; Diederich M
Biochem Pharmacol; 2004 Apr; 67(7):1227-38. PubMed ID: 15013838
[TBL] [Abstract][Full Text] [Related]
16. MEKK1-induced apoptosis requires TRAIL death receptor activation and is inhibited by AKT/PKB through inhibition of MEKK1 cleavage.
Bild AH; Mendoza FJ; Gibson EM; Huang M; Villanueva J; Garrington TP; Jove R; Johnson GL; Gibson SB
Oncogene; 2002 Sep; 21(43):6649-56. PubMed ID: 12242663
[TBL] [Abstract][Full Text] [Related]
17. Nuclear factor-kappaB dimer exchange promotes a p21(waf1/cip1) superinduction response in human T leukemic cells.
Chang PY; Miyamoto S
Mol Cancer Res; 2006 Feb; 4(2):101-12. PubMed ID: 16513841
[TBL] [Abstract][Full Text] [Related]
18. Proapoptotic effects of NF-kappaB on cisplatin-induced cell death in auditory cell line.
Chung WH; Boo SH; Chung MK; Lee HS; Cho YS; Hong SH
Acta Otolaryngol; 2008 Oct; 128(10):1063-70. PubMed ID: 18607991
[TBL] [Abstract][Full Text] [Related]
19. PI3-kinase and PDK-1 regulate HDAC1-mediated transcriptional repression of transcription factor NF-kappaB.
Choi YS; Jeong S
Mol Cells; 2005 Oct; 20(2):241-6. PubMed ID: 16267399
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of extracellular signal-regulated kinase 1/2, p38 mitogen-activated protein kinase and nuclear translocation of nuclear factor-kappaB are involved in upregulation of matrix metalloproteinase-9 by tumour necrosis factor-alpha.
Itatsu K; Sasaki M; Harada K; Yamaguchi J; Ikeda H; Sato Y; Ohta T; Sato H; Nagino M; Nimura Y; Nakanuma Y
Liver Int; 2009 Feb; 29(2):291-8. PubMed ID: 18710428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
